Literature DB >> 33895402

Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States.

Neel S Bhatt1, Ruta Brazauskas2, Rachel B Salit3, Karen Syrjala3, Stephanie Bo-Subait4, Heather Tecca5, Sherif M Badawy6, K Scott Baker3, Amer Beitinjaneh7, Nelli Bejanyan8, Michael Byrne9, Ajoy Dias10, Nosha Farhadfar11, César O Freytes12, Siddhartha Ganguly13, Shahrukh Hashmi14, Robert J Hayashi15, Sanghee Hong16, Yoshihiro Inamoto17, Kareem Jamani18, Kimberly A Kasow19, Nandita Khera20, Maxwell M Krem21, Hillard M Lazarus22, Catherine J Lee23, Stephanie Lee24, Navneet S Majhail16, Adriana K Malone25, David I Marks26, Lih-Wen Mau4, Samantha J Mayo27, Lori S Muffly28, Sunita Nathan29, Taiga Nishihori8, Kristin M Page30, Jaime Preussler4, Hemalatha G Rangarajan31, Seth J Rotz32, Nina Salooja33, Bipin N Savani34, Raquel Schears35, Tal Schechter-Finkelstein36, Gary Schiller37, Ami J Shah38, Akshay Sharma39, Trent Wang7, Baldeep Wirk40, Minoo Battiwalla41, Hélène Schoemans42, Betty Hamilton16, David Buchbinder43, Rachel Phelan5, Bronwen Shaw5.   

Abstract

Young adult (YA) survivors of allogeneic hematopoietic cell transplantation (HCT) are at risk for late psychosocial challenges, including the inability to return to work post-HCT. Work-related outcomes in this population remain understudied, however. We conducted this study to assess the post-HCT work status of survivors of allogeneic HCT who underwent HCT as YAs and to analyze the patient-, disease-, and HCT-related factors associated with their work status at 1 year post-HCT. Using Center for International Blood and Marrow Transplant Research data, we evaluated the post-HCT work status (full-time, part-time work, unemployed, or medical disability) of 1365 YA HCT survivors who underwent HCT between 2008 and 2015. Percentages of work status categories were reported at 4 time points: 6 months, 1 year, 2 years, and 3 years post-HCT. Percentages of post-HCT work status categories at the 1-year time point were also described in relation to survivors' pre-HCT work status categories. Factors associated with 1-year post-HCT work status (full-time or part-time work) were examined using logistic regression. From 6 months to 3 years post-HCT, the percentage of survivors working full-time increased from 18.3% to 50.7% and the percentage working part-time increased from 6.9% to 10.5%. Of patients in full-time work pre-HCT, 50% were unemployed or on medical disability at 1 year post-HCT. Female sex (odds ratio [OR], 0.55; 95% confidence interval [CI], 0.40 to 0.77), HCT Comorbidity Index score ≥3 (OR, 0.57; 95% CI, 0.39 to 0.82), pre-HCT unemployment (OR, 0.37; 95% CI, 0.24 to 0.56), medical disability (OR, 0.44; 95% CI, 0.28 to 0.70), development of grade III-IV acute graft-versus-host disease (OR, 0.52; 95% CI, 0.34 to 0.80), and relapse within 1 year post-HCT (OR, 0.34; 95% CI, 0.21 to 0.56) were associated with a lower likelihood of employment at 1 year post-HCT. Compared with myeloablative conditioning (MAC) with total body irradiation (TBI), MAC without TBI (OR, 1.71; 95% CI, 1.16 to 2.53) was associated with a greater likelihood of employment at 1 year post-HCT. Graduate school-level education (OR, 2.47; 95% CI, 1.49 to 4.10) was also associated with a greater likelihood of employment at 1 year post-HCT. Although the work status among YA HCT survivors continued to improve over time, a substantial subset became or remained unemployed or on medical disability. These findings underscore the need for effective interventions to support return to work in this population.
Copyright © 2021 The American Society for Transplantation and Cellular Therapy. All rights reserved.

Entities:  

Keywords:  Hematopoietic cell transplantation; Quality of life; Return to work; Young adult

Mesh:

Year:  2021        PMID: 33895402      PMCID: PMC8425287          DOI: 10.1016/j.jtct.2021.04.013

Source DB:  PubMed          Journal:  Transplant Cell Ther        ISSN: 2666-6367


  33 in total

1.  Educational and vocational goal disruption in adolescent and young adult cancer survivors.

Authors:  Janine Vetsch; Claire E Wakefield; Brittany C McGill; Richard J Cohn; Sarah J Ellis; Natalie Stefanic; Susan M Sawyer; Brad Zebrack; Ursula M Sansom-Daly
Journal:  Psychooncology       Date:  2017-09-11       Impact factor: 3.894

2.  Hematopoietic stem cell transplantation: a global perspective.

Authors:  Alois Gratwohl; Helen Baldomero; Mahmoud Aljurf; Marcelo C Pasquini; Luis Fernando Bouzas; Ayami Yoshimi; Jeff Szer; Jeff Lipton; Alvin Schwendener; Michael Gratwohl; Karl Frauendorfer; Dietger Niederwieser; Mary Horowitz; Yoshihisa Kodera
Journal:  JAMA       Date:  2010-04-28       Impact factor: 56.272

Review 3.  Return to work after a cancer diagnosis: a meta-review of reviews and a meta-synthesis of recent qualitative studies.

Authors:  Phyllis Butow; Rebekah Laidsaar-Powell; Stephanie Konings; Chloe Yi Shing Lim; Bogda Koczwara
Journal:  J Cancer Surviv       Date:  2019-12-19       Impact factor: 4.442

4.  Inability to work and need for disability pension among long-term survivors of hematopoietic stem cell transplantation.

Authors:  A Tichelli; S Gerull; A Holbro; A Buser; G Nair; M Medinger; D Heim; J P Halter; J R Passweg
Journal:  Bone Marrow Transplant       Date:  2017-06-26       Impact factor: 5.483

5.  Quality of life concerns and depression among hematopoietic stem cell transplant survivors.

Authors:  Catherine E Mosher; Katherine N DuHamel; Christine Rini; Geoffrey Corner; Joanne Lam; William H Redd
Journal:  Support Care Cancer       Date:  2010-07-27       Impact factor: 3.603

6.  Patient-reported outcomes in survivors of childhood hematologic malignancies with hematopoietic stem cell transplant.

Authors:  Hsiu-Ju Yen; Hesham M Eissa; Neel S Bhatt; Sujuan Huang; Matthew J Ehrhardt; Nickhill Bhakta; Kirsten K Ness; Kevin R Krull; D Kumar Srivastava; Leslie L Robison; Melissa M Hudson; I-Chan Huang
Journal:  Blood       Date:  2020-05-21       Impact factor: 22.113

7.  Prospective predictors of return to work in the 5 years after hematopoietic cell transplantation.

Authors:  Anne C Kirchhoff; Wendy Leisenring; Karen L Syrjala
Journal:  J Cancer Surviv       Date:  2010-03       Impact factor: 4.442

8.  Return to Work and Employment Situation of Young Adult Cancer Survivors: Results from the Adolescent and Young Adult-Leipzig Study.

Authors:  Katja Leuteritz; Michael Friedrich; Annekathrin Sender; Diana Richter; Anja Mehnert-Theuerkauf; Siegfried Sauter; Kristina Geue
Journal:  J Adolesc Young Adult Oncol       Date:  2020-08-03       Impact factor: 2.223

9.  Employment Status as an Indicator of Recovery and Function One Year after Hematopoietic Stem Cell Transplantation.

Authors:  Eleshia J Morrison; Shawna L Ehlers; Carrie A Bronars; Christi A Patten; Tabetha A Brockman; James R Cerhan; William J Hogan; Shahrukh K Hashmi; Dennis A Gastineau
Journal:  Biol Blood Marrow Transplant       Date:  2016-05-21       Impact factor: 5.742

Review 10.  Current Use of and Trends in Hematopoietic Cell Transplantation in the United States.

Authors:  Anita D'Souza; Caitrin Fretham; Stephanie J Lee; Mukta Arora; Janet Brunner; Saurabh Chhabra; Steven Devine; Mary Eapen; Mehdi Hamadani; Parameswaran Hari; Marcelo C Pasquini; Waleska Perez; Rachel A Phelan; Marcie L Riches; J Douglas Rizzo; Wael Saber; Bronwen E Shaw; Stephen R Spellman; Patricia Steinert; Daniel J Weisdorf; Mary M Horowitz
Journal:  Biol Blood Marrow Transplant       Date:  2020-05-11       Impact factor: 5.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.